Ignite Creation Date:
2025-12-25 @ 3:16 AM
Ignite Modification Date:
2026-05-17 @ 2:27 AM
Study NCT ID:
NCT06937905
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-04-22
First Post:
2025-04-14
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Tarlatamab vs Standard of Care Chemotherapy in Patients With Pre-treated Advanced, Pulmonary or Gastroenteropancreatic Poorly Differentiated Neuroendocrine Carcinomas (NECs)
Sponsor:
Intergroupe Francophone de Cancerologie Thoracique
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Neuroendocrine Carcinoma | View |